[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-362308-105":59,"doc-detail-362308-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ifi16ifi202-blockade-suppresses-tumor-growth-through-cd8-t-cellmediated-immunity","IFI16/IFI202 blockade suppresses tumor growth through CD8+ T-cell–mediated immunity","","Tumor-associated macrophages (TAMs) drive immunosuppressive inflammation in the breast cancer microenvironment, promoting tumor progression and limiting immune checkpoint blockade. Previous findings implicated extracellular IFI16/IFI202 as tumor-derived damage-associated molecular patterns that trigger pro-inflammatory signaling in TAMs via Toll-like receptor 2, enabling immune evasion. This study evaluates a monoclonal antibody targeting extracellular IFI202 to reduce TAM-mediated inflammation and restore CD8+ T-cell antitumor immunity, including therapeutic and combinatorial effects.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ifi16ifi202-blockade-suppresses-tumor-growth-through-cd8-t-cellmediated-immunity/362308/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ifi16ifi202-blockade-suppresses-tumor-growth-through-cd8-t-cellmediated-immunity/362308.png","ImageObject",300,407,{"name":92,"@type":93},"Valentina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does extracellular IFI16/IFI202 play in breast cancer immune evasion?","Question",{"text":112,"@type":113},"Extracellular IFI16/IFI202 functions as tumor-derived damage-associated molecular patterns that activate pro-inflammatory signaling in TAMs via Toll-like receptor 2, facilitating immune escape.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the anti-IFI202 monoclonal antibody evaluated in this study?",{"text":117,"@type":113},"A monoclonal antibody against IFI202 was generated and tested in bone marrow-derived macrophages using ELISA and western blotting, followed by in vivo efficacy studies in a breast cancer mouse model.",{"name":119,"@type":110,"acceptedAnswer":120},"What impact did IFI202 antibody treatment have on tumor growth and T-cell function?",{"text":121,"@type":113},"IFI202 mAb treatment reduced tumor growth and lung metastasis, enhanced IL-1β expression, increased CD8+ T-cell infiltration, and elevated granzyme B and interferon-γ, indicating restored cytotoxic CD8+ T-cell activity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},362308,1790197101,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","Lim etal. Breast Cancer Research (2026) 28:27 Breast Cancer Research  \n[https://doi.org/10.1186/s13058-025-02213-4](https://doi.org/10.1186/s13058-025-02213-4)  \nRESEARCH Open Access  \nIFI16/IFI202 blockade suppresses tumor growth through CD8+ T-cell–mediated immunity  \nGa Young Lim1†, Na-Lee Ka2†, Seung-Su Kim 1 and Mi-Ock Lee 1,3*  \nAbstract  \nBackground Tumor-associated macrophages (TAMs) are key drivers of immunosuppressive inflammation in the breast cancer microenvironment, promoting tumor progression and resistance to immune checkpoint blockade. Our previous work identified extracellular IFI16/IFI202 as tumor-derived damage-associated molecular patterns which activate pro-inflammatory signaling inTAMs via Toll-like receptor 2, thereby facilitating immune evasion. In this study, we investigated the therapeutic potential of a monoclonal antibody (mAb) targeting extracellular IFI202 to suppress tumor-promoting inflammation and to restore antitumor immunity.  \nMethods We developed a mAb against IFI202 and evaluated its functions in bone marrow-derived macrophages (BMDMs) using ELISA and western blotting. In vivo efficacy was assessed in the mouse mammary tumor viruspolyoma virus middle T-antigen breast cancer model by treating with IFI202 mAb, or anti–programmed death-1 (PD-1) antibody, as monotherapies or in combination. Tumor volume, metastasis, cytokine levels, and immune cell infiltration were analyzed. Statistical significance was assessed using Mann–Whitney U test or ANOVA, with P \u003C 0.05 considered significant.  \nResults Conditioned medium obtained from 4T1 breast cancer cells pre-incubated with IFI202 mAb suppressed secretion of IL-6 and TNF-α, and inhibited activation of ERK and NF-κB in BMDMs. Intraperitoneal injection of IFI202 mAb in mouse mammary tumor virus-polyoma middle T-antigen mice significantly reduced tumor growth and lung metastasis. In addition, IL-1β expression, CD8+ T cell infiltration, and levels of granzyme B and interferon-γ, were enhanced in the tumors of IFI202 mAb-treated mice, indicating that IFI202 mAb restored cytotoxic function of CD8+ T-cells. Combination of IFI202 mAb with PD-1 mAb significantly improved antitumor efficacy compared tomonotherapy.  \nConclusions Neutralization of extracellular IFI202 suppresses TAM-mediated inflammation and supports a tumor microenvironment favorable forT-cell–mediated immunity. In combination with anti–PD-1 therapy, IFI202 mAb further enhances antitumor responses, suggesting a promising and tumor-selective strategy that may help overcome resistance to immune checkpoint blockade in breast cancer.  \n†Ga Young Lim and Na-Lee Ka have contributed equally to this work.  \n*Correspondence: Mi-Ock Lee [molee@snu.ac.kr](molee@snu.ac.kr)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nLim et al. Breast Cancer Research","cbCaikZhJExVFESE","https://ap.wps.com/l/cbCaikZhJExVFESE","pdf",4334503,"English","# Abstract\n# Background\n## Tumor microenvironment and TAMs\n## Immune suppression and checkpoint blockade resistance\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What role does extracellular IFI16/IFI202 play in breast cancer immune evasion?\",\"answer\":\"Extracellular IFI16/IFI202 functions as tumor-derived damage-associated molecular patterns that activate pro-inflammatory signaling in TAMs via Toll-like receptor 2, facilitating immune escape.\"},{\"question\":\"How was the anti-IFI202 monoclonal antibody evaluated in this study?\",\"answer\":\"A monoclonal antibody against IFI202 was generated and tested in bone marrow-derived macrophages using ELISA and western blotting, followed by in vivo efficacy studies in a breast cancer mouse model.\"},{\"question\":\"What impact did IFI202 antibody treatment have on tumor growth and T-cell function?\",\"answer\":\"IFI202 mAb treatment reduced tumor growth and lung metastasis, enhanced IL-1β expression, increased CD8+ T-cell infiltration, and elevated granzyme B and interferon-γ, indicating restored cytotoxic CD8+ T-cell activity.\"}]","IFI16/IFI202 blockade suppresses tumor growth through CD8+ T-cell–mediated immunity | PDF",1790147005,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ad4c2852f9867aac7a8a2c65ca0e3db.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a9495b36410e2a969794187114170be5.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd8c8b2e476695e7041286c3b3c685cc.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5a302c8bc366a87868c08b0f7e66bc71.webp",980,1306]